Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$799M |
| 2 |
Broadcom
AVGO
|
$472M |
| 3 |
Chipotle Mexican Grill
CMG
|
$309M |
| 4 |
Advanced Micro Devices
AMD
|
$296M |
| 5 |
Apple
AAPL
|
$275M |
Top Sells
| 1 |
Amazon
AMZN
|
$536M |
| 2 |
Uber
UBER
|
$438M |
| 3 |
Chevron
CVX
|
$280M |
| 4 |
Meta Platforms (Facebook)
META
|
$264M |
| 5 |
CrowdStrike
CRWD
|
$242M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 18.08% |
| 3 | Consumer Discretionary | 13.75% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Progressive
PGR
$144B
| $148M | 0.25% |
711,600
-85,600
| -11% | -$17.8M |
|
77
Permian Resources
PR
$9.79B
| $147M | 0.25% |
9,108,803
+1,555,884
| +21% | +$25.1M |
|
78
Microsoft
MSFT
$3.74T
| $145M | 0.25% |
+324,925
| New | +$145M |
|
79
Biogen
BIIB
$20.8B
| $143M | 0.24% |
618,106
-266,598
| -30% | -$61.8M |
|
80
Teva Pharmaceuticals
TEVA
$21.4B
| $142M | 0.24% |
8,728,563
+1,031,400
| +13% | +$16.8M |
|
81
Manhattan Associates
MANH
$12.6B
| $139M | 0.24% |
565,160
-26,400
| -4% | -$6.51M |
|
82
Rollins
ROL
$27.2B
| $138M | 0.23% |
2,825,569
+133,100
| +5% | +$6.49M |
|
83
Alkermes
ALKS
$4.97B
| $132M | 0.22% |
5,483,831
-403,320
| -7% | -$9.72M |
|
84
PayPal
PYPL
$66.2B
| $132M | 0.22% |
2,267,178
-17,522
| -0.8% | -$1.02M |
|
85
Pfizer
PFE
$141B
| $132M | 0.22% |
4,700,173
+735,536
| +19% | +$20.6M |
|
86
Las Vegas Sands
LVS
$38B
| $131M | 0.22% |
2,949,670
+903,400
| +44% | +$40M |
|
87
Thermo Fisher Scientific
TMO
$182B
| $130M | 0.22% |
+235,849
| New | +$130M |
|
88
Flowers Foods
FLO
$3.11B
| $130M | 0.22% |
5,851,682
+242,797
| +4% | +$5.39M |
|
89
Li Auto
LI
$24.5B
| $130M | 0.22% |
7,253,500
-87,700
| -1% | -$1.57M |
|
90
Cal-Maine
CALM
$5.39B
| $129M | 0.22% |
2,115,624
+110,900
| +6% | +$6.78M |
|
91
TKO Group
TKO
$15.3B
| $127M | 0.21% |
1,173,000
-444,300
| -27% | -$48M |
|
92
Accenture
ACN
$157B
| $125M | 0.21% |
+412,400
| New | +$125M |
|
93
WIX.com
WIX
$7.89B
| $125M | 0.21% |
785,649
+171,500
| +28% | +$27.3M |
|
94
Hims & Hers Health
HIMS
$10.2B
| $122M | 0.21% |
6,039,408
+3,205,108
| +113% | +$64.7M |
|
95
CME Group
CME
$96.5B
| $122M | 0.21% |
618,589
-230,100
| -27% | -$45.2M |
|
96
Union Pacific
UNP
$130B
| $121M | 0.21% |
535,000
+21,821
| +4% | +$4.94M |
|
97
Wynn Resorts
WYNN
$13.1B
| $120M | 0.2% |
1,345,100
+303,033
| +29% | +$27.1M |
|
98
Ryanair
RYAAY
$32.8B
| $120M | 0.2% |
1,033,151
-86,200
| -8% | -$10M |
|
99
Mondelez International
MDLZ
$78.7B
| $118M | 0.2% |
1,804,722
+1,260,124
| +231% | +$82.5M |
|
100
Chunghwa Telecom
CHT
$33.7B
| $118M | 0.2% |
3,058,180
+7,100
| +0.2% | +$274K |
|